Cg. Cochrane et al., BRONCHOALVEOLAR LAVAGE WITH KL4-SURFACTANT IN MODELS OF MECONIUM ASPIRATION SYNDROME, Pediatric research, 44(5), 1998, pp. 705-715
As a model of the meconium aspiration syndrome (MAS) of human infants,
adult rabbits and newborn rhesus monkeys received intratracheal insti
llation of human meconium to induce pulmonary injury. Injured rabbits
were ventilated with 100% O-2 and divided into four treatment groups,
receiving: I) bronchoalveolar lavages (BAL) with dilute KL4-Surfactant
; 2) lavages with equal volumes of sterile saline; 3) a single intratr
acheal bolus of KL4-Surfactant, 100 mg/kg; and 4) no treatment. The un
treated rabbits developed atelectasis, a fall in pressure-volume level
s and in partial pressure of O-2 in arterial blood (Pao(3) from approx
imately 500 to <100 mmHg, and severe pulmonary inflammation between 3
and 5 h after instillation of meconium. Rabbits treated by BAL with di
lute KL4-Surfactant showed rapid and sustained recovery of Pao(2) to a
pproximately 300 mm Hg within minutes, a return toward normal pressure
-volume levels, and diminished inflammation, Rabbits receiving BAL wit
h saline failed to show recovery, and rabbits treated with a bolus of
surfactant intratracheally exhibited a transient response by 1-2 h aft
er treatment, but then returned to the initial atelectatic state. Newb
orn rhesus monkeys, after receiving human meconium intratracheally bef
ore the first breath, developed severe loss of pulmonary function. Tre
atment of these monkeys 1-5 h after birth with BAL with dilute KL4-Sur
factant produced clearing of chest radiographs and a rapid improvement
in pulmonary function with ratios of partial pressure of O-2 in arter
ial blood to the fraction of O-2 in the inspired air rising into the n
ormal range where they remained through the 20-h period of study. The
studies indicate that pulmonary function in two models of severe mecon
ium injury respond rapidly to BAL with dilute KL4-Surfactant.